Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of coronary arteries bypass grafting (CABG) and percutaneous coronary intervention (PCI) through drug stent in iran: a comparative study.
Fakhrzad, NourolHoda; Barouni, Mohsen; Goudarzi, Reza; Kojuri, Javad; Jahani, Yunes; Tasavon Gholamhoseini, Mohammad.
Afiliação
  • Fakhrzad N; Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
  • Barouni M; Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. Mohsenbarooni@gmail.com.
  • Goudarzi R; Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
  • Kojuri J; Chairman of Education Development Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Jahani Y; Department of Biostatistics and Epidemiology, School of Public Health, Kerman University of Medical Sciences, Kerman, Iran.
  • Tasavon Gholamhoseini M; Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Cost Eff Resour Alloc ; 21(1): 16, 2023 Feb 15.
Article em En | MEDLINE | ID: mdl-36793078
ABSTRACT

BACKGROUND:

Cost-effectiveness analysis plays a key role in evaluating health systems and services. Coronary artery disease is one of the primary health concerns worldwide. This study sought to compare the cost-effectiveness of Coronary Arteries Bypass Grafting (CABG) and Percutaneous Coronary Intervention (PCI) through drug stent using Quality-Adjusted Life Years (QALY) index.

METHODS:

This is a cohort study involving all patients undergoing CABG and PCI through drug stent in south of Iran. A total of 410 patients were randomly selected to be included in the study. Data were gathered using SF-36, SAQ and a form for cost data from the patients' perspective. The data were analyzed descriptively and inferentially. Considering the analysis of cost-effectiveness, Markov Model was initially developed using TreeAge Pro 2020. Both deterministic and probabilistic sensitivity analyses were performed.

RESULTS:

Compared with the group treated with PCI, the total cost of interventions was higher in the CABG group ($102,103.8 vs $71,401.22) and the cost of lost productivity ($20,228.68 vs $7632.11), while the cost of hospitalization was lower in CABG ($67,567.1 vs $49,660.97). The cost of hotel stay and travel ($6967.82 vs $2520.12) and the cost of medication ($7340.18 vs $11,588.01) was lower in CABG. From the patients' perspective and SAQ instrument, CABG was cost-saving, with a reduction of $16,581 for every increase in effectiveness. Based on patients' perspective and SF-36 instrument, CABG was cost-saving, with a reduction of $34,543 for every increase in effectiveness.

CONCLUSION:

In the same indications, CABG intervention leads to more resource savings.
Palavras-chave

Texto completo: 1 Temas: ECOS / Financiamentos_gastos Bases de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Observational_studies Aspecto: Patient_preference Idioma: En Revista: Cost Eff Resour Alloc Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Temas: ECOS / Financiamentos_gastos Bases de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Observational_studies Aspecto: Patient_preference Idioma: En Revista: Cost Eff Resour Alloc Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã